Last updated: 2026-10-13 18:44:00. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Indivior Pharmaceuticals, Inc. (INDV) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $35.76, with a market capitalization of $4.23B and a P/E ratio of 11.99. Over the past 52 weeks, its price has ranged from $23.55 to $42.81. This page covers its latest market performance, valuation, price trends and company information.
$4.23B | |
$36.09 | |
$42.81 | |
$7.33 | |
$36.06 | |
738.05K | |
2.25M | |
11.99 | |
$42.81 | |
$23.55 | |
-- | |
-- |
Indivior Pharmaceuticals, Inc. (INDV) is currently trading at $35.76 as of 2026-10-13 18:28:31, down 0.82% ($0.30) from the previous close of $36.06
During today's regular trading session, INDV has traded between $7.33 and $42.81, with a trading volume of 738.05K shares. The current price is near the upper end of today's range.
Over the past seven days, Indivior Pharmaceuticals, Inc. (INDV) moved from $35.71 to $35.76, representing a gain of 0.15% ($0.05).
The stock traded between $34.85 and $36.56 during the period. The latest price is near the middle of the 7-day range, indicating range-bound.
The average daily volume was 3.23 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 63.4%
INDV is currently trading at $35.76, placing it 63.4% of the way from its 52-week low of $23.55 to its 52-week high of $42.81. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 838 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Indivior Pharmaceuticals, Inc. (INDV) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.